COSMOS HEALTH INC.

NASDAQ: COSM (Cosmos Health Inc.)

Kemas kini terakhir: 3 hari lalu, 4:11AM

0.496

0.01 (1.04%)

Penutupan Terdahulu 0.491
Buka 0.480
Jumlah Dagangan 887,082
Purata Dagangan (3B) 833,459
Modal Pasaran 17,320,280
Harga / Jualan (P/S) 0.290
Harga / Buku (P/B) 0.970
Julat 52 Minggu
0.280 (-43%) — 1.32 (166%)
Tarikh Pendapatan 16 Apr 2025
Margin Keuntungan -28.26%
Margin Operasi (TTM) -6.08%
EPS Cair (TTM) -1.09
Pertumbuhan Hasil Suku Tahunan (YOY) -6.00%
Jumlah Hutang/Ekuiti (D/E MRQ) 49.51%
Nisbah Semasa (MRQ) 1.05
Aliran Tunai Operasi (OCF TTM) -4.49 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -1.94 M
Pulangan Atas Aset (ROA TTM) -14.90%
Pulangan Atas Ekuiti (ROE TTM) -50.03%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Distribution (US) Bercampur Bercampur
Medical Distribution (Global) Bercampur Menaik
Stok Cosmos Health Inc. - -

AISkor Stockmoo

1.0
Konsensus Penganalisis 0.0
Aktiviti Orang Dalam 5.0
Volatiliti Harga -2.0
Purata Bergerak Teknikal 2.5
Osilator Teknikal -0.5
Purata 1.00

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
COSM 17 M - - 0.970
HSIC 9 B - 23.15 2.55
QIPT 107 M - - 1.03
EDAP 86 M - - 3.32
ZYXI 16 M - - 34.84
AHG 829 M - - 4.11

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

Sektor Healthcare
Industri Medical Distribution
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 31.08%
% Dimiliki oleh Institusi 9.46%

Tiada data dalam julat masa ini.

Nama Purata Belian ($) Purata Jualan ($) Jumlah Net Jumlah Nilai Bersih ($)
SIOKAS GRIGORIOS 0.635 - 132,092 84,023
Jumlah Keseluruhan Kuantiti Bersih 132,092
Jumlah Keseluruhan Nilai Bersih ($) 84,023
Purata Pembelian Keseluruhan ($) 0.635
Purata Jualan Keseluruhan ($) -
Nama Pemegang Tarikh Jenis Kuantiti Harga Nilai ($)
SIOKAS GRIGORIOS Pegawai 28 Nov 2025 Beli (+) 76,360 0.642 49,023
SIOKAS GRIGORIOS Pegawai 25 Nov 2025 Beli (+) 55,732 0.628 35,000
Tarikh Jenis Butiran
03 Dec 2025 Pengumuman Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
03 Dec 2025 Pengumuman Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
02 Dec 2025 Pengumuman Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
02 Dec 2025 Pengumuman Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
17 Nov 2025 Pengumuman Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
17 Nov 2025 Pengumuman Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
31 Oct 2025 Pengumuman Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
31 Oct 2025 Pengumuman Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
21 Oct 2025 Pengumuman Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
21 Oct 2025 Pengumuman Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
16 Oct 2025 Pengumuman Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement
16 Oct 2025 Pengumuman Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement
13 Oct 2025 Pengumuman Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
13 Oct 2025 Pengumuman Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
10 Oct 2025 Pengumuman Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
10 Oct 2025 Pengumuman Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
03 Oct 2025 Pengumuman Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
03 Oct 2025 Pengumuman Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
29 Sep 2025 Pengumuman Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
29 Sep 2025 Pengumuman Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
25 Sep 2025 Pengumuman Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually
25 Sep 2025 Pengumuman Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually
22 Sep 2025 Pengumuman Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
22 Sep 2025 Pengumuman Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
11 Sep 2025 Pengumuman Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
11 Sep 2025 Pengumuman Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda